Doris P. Tabassum

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu, Charles Y. Lin, Housheng Hansen He et al. · Nature · 2016 · 616 citations · Full text

Breast Oncology, Medicine, Immunology +9

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

Andriy Marusyk, Doris P. Tabassum, Philipp M. Altrock et al. · Nature · 2014 · 605 citations · Full text

Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments

Michalina Janiszewska, Doris P. Tabassum, Zafira Castaño et al. · Nature Cell Biology · 2019 · 155 citations · Full text

Immune Evasion, Cancer Immunosurveillance, Systemic Immune Microenvironments +9

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes

Andriy Marusyk, Doris P. Tabassum, Michalina Janiszewska et al. · Cancer Research · 2016 · 139 citations · Full text

Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer

Byunghee Yoo, Amol Kavishwar, Alana Ross et al. · Cancer Research · 2015 · 74 citations · Full text

Breast Oncology, Nanotherapeutics, Engineering +20